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Editorial
Brexit and What It Means for Global Health
Brian Greenwood*
Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom
The results of a referendumheld in theUnited Kingdom (UK)
on June 23, 2016 in which 33 million voters decided by a
margin of 51.9–48.1% to leave the European Union (EU) came
as a shock tomany in the UKwho had been conﬁdent that this
would not be the case, and was accompanied by a sense of
disbelief among many outside the UK. Subsequent analysis
has shown that the “leave” vote was highest in the oldest age
groups, those with less formal education, and in areas out-
side themainmetropolitan centers; young voters and residents
of citieswith a strongacademiccenterwere strongly in favorof
“remain.” The vote provided a binary choice of leave or not,
with no opportunity to consider the kind of arrangements that
would follow a decision to leave. In the 18 months after the
referendum, protracted discussions have taken place be-
tween the UK government and the European Commission on
the nature of Brexit. Some progress has been made in these
discussions on the “divorce bill,” the status of European citi-
zens resident in theUK, and vice-versa, andonhow theborder
between Northern Ireland and the Republic of Ireland, which
will remain in the EU, will be managed. Negotiations will now
move onto broader issues such as trade, and these negotia-
tions will include discussions on the future relationship be-
tween theUKand theEUonscience and innovation.However,
it is still not clear whether a ﬁnal agreement will be reached
before the UK leaves the EU on March 29, 2019 and, if an
agreement is reached, what form this might take. If an
agreement is reached, it is likely that some kind of transition
period will be needed to allow the new arrangements to be
implemented.
The outcome of the Brexit referendum will have major
consequences for the UK in many areas, including health and
science. The UKNational Health Service is very dependent on
contributions of doctors and nurses from EU countries,
and recruitment of staff from the EU has already fallen sub-
stantially. The decision to move the European Medicines
Agency, Europe’s regulatory agency, from London to Amster-
dam could inﬂuence major pharmaceutical agencies re-
garding investment in the UK, including agencies involved in
developingmedicines for the developingworld. The decision
to leave is amajor concern for UK scientists because it is now
unclear whether they will in future be able to access research
funds provided by the EU, amajor source of ﬁnancial support
for many UK universities and research institutions, and
whether they will be able to continue to recruit talented Eu-
ropean researchers to their research groups.
Should the Brexit decision be of any interest or concern to
readers of the American Journal of Tropical Medicine and
Hygiene who live outside the UK? I believe that it should for
several reasons. First, the decision to leave the EUmay impair
the future ability of UK scientists to work effectively in part-
nershipwith colleagues in theEUandelsewhere inmanyareas
of science, including global health, a ﬁeld in which UK scien-
tists currently play an important role. The UK government has
promised to cover the costs of existing grants provided by EU
institutions after departure from the EU, but howUK scientists
will be able to participate in EU supported research projects
after that date remains uncertain. For example, it is uncertain
whether UK scientists will be eligible to apply for funding from
the European Developing Countries Clinical Trials Partner-
ship, an important sourceof support for collaborative research
and research capacity development projects linking European
scientists and those from developing countries. Second, the
Brexit decision could have a direct impact on funding for
global health. Currently, the UK is one of the most generous
donors to international organisations concerned with global
health such as the Global Fund and the Global Alliance for
Vaccination and Immunization, and a strong supporter of
public–private partnerships involved in the development of
products for the developing world such as the Medicines for
Malaria Venture. Although there is no certainty over the ﬁ-
nancial impact of Brexit on the UK economy, and this will
depend to some extent on the nature of the ﬁnal deal, most of
the ﬁnancial experts reckon that therewill be a downturn in the
UK economy after Brexit, at least in the short term. Currently
the UK government is providing substantial ﬁnancial support
to national research on global health issues through a Global
Challenges Research Fund, but should Brexit lead to a
downturn in the overall economy, the government will have
less money overall to spend and may change its priorities to
issues of more local concern. Finally, the leave vote suggests
that there has been a change in attitude among a signiﬁcant
proportionof thepopulationof theUK towardamoreparochial
view of the place of theUK in theworld and away from the idea
that a wealthy country such as the UK should be making a
major contribution tomeeting the challenges that threaten the
world as a whole such as global warming, food security, mi-
gration, and tropical infectious disease, a change in attitude
also apparent in some other western democracies including
the USA. The success of the Brexit “leavers” could encourage
those with similar views in other countries within the EU and
elsewhere to press for a similar change in direction.
A high proportion of UK scientists were against leaving the
EU, especially those involved in global health, but after a pe-
riod of initial shock and a lot of whinging, there has now been
recognition that unless there is some completely unexpected
turn of events, the UK is on course to leave the EU on March
29, 2019. Consequently, efforts are now being made by the
UK’s scientiﬁc community to try to mitigate the potentially
damaging impact of Brexit on UK science and to maintain the
ability of UK scientists to contribute to international chal-
lenges. Led by institutions such as the Royal Society, the
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Wellcome Trust, andmajor academic institutions, includingmy
own, the government has been intensively lobbied to ensure
thatarrangements foreasymovementofscientistsbetween the
UKand theEU isgivenprominence in theongoingnegotiations.
Another option that is being explored by UK universities and
research institutions is establishment of partnerships with EU
institutions that will allowUK institutions to accessEU research
funds, but it is unlikely that this will be acceptable to the EU
unless these are true partnerships andnot just paper exercises.
Ensuring that global health is not neglected should Brexit lead
to a signiﬁcant ﬁnancial downturn in the UK will be a major
challenge, especially considering an increasing skepticism
concerning the value of overseas aid. Ensuring continuing UK
government support for national global health activities and for
major international organisations for which the UK is a strong
ﬁnancial supporter will require a committed effort from UK
scientists, a task that could be helped by support from aca-
demic institutions in the EU and more widely.
The decision of the UK to leave the EU has been a bad
one for UK science overall, potentially reducing its ability to
contribute to research on issues related to global health and
also to sustain its major development programs. However,
imaginativeways are being explored tomeet these challenges
and to ensure that the UK can continue to collaborate with its
partners in the EU and elsewhere to continue to make a major
contribution to global health.
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